Skip to main content

Published locations for Venetoclax achieves a high undetectable measurable residual disease rate in ibrutinib-treated high-risk CLL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Venetoclax achieves a high undetectable measurable residual disease rate in ibrutinib-treated high-risk CLL

User login

  • Reset your password
  • /content/venetoclax-achieves-high-undetectable-measurable-residual-disease-rate-ibrutinib-treated
  • /b-cell-lymphoma-icymi/article/263079/b-cell-lymphoma/venetoclax-achieves-high-undetectable